Sunilkumar S, Subrahmanian S, Yerlikaya E, Toro A, Harhaj E, Kimball S
Cell Death Dis. 2025; 16(1):79.
PMID: 39920111
PMC: 11806006.
DOI: 10.1038/s41419-025-07396-4.
Zeb M, Dumont E, Khan M, Shehzadi A, Ahmad I
Vaccines (Basel). 2024; 12(11).
PMID: 39591153
PMC: 11598688.
DOI: 10.3390/vaccines12111250.
Katagiri D, Nagasaka S, Takahashi K, Wang S, Pozzi A, Zent R
Sci Rep. 2024; 14(1):29179.
PMID: 39587144
PMC: 11589149.
DOI: 10.1038/s41598-024-79501-0.
Morones J, Perez M, Munoz M, Sanchez E, Avila M, Topete J
Int J Mol Sci. 2024; 25(21).
PMID: 39518925
PMC: 11545748.
DOI: 10.3390/ijms252111372.
Lin Y, Du W, Fu X, Huang L, Hong Y, Tan H
Front Pharmacol. 2024; 15:1395887.
PMID: 39108749
PMC: 11300211.
DOI: 10.3389/fphar.2024.1395887.
Loss of 3-O-sulfotransferase enzymes, Hs3st3a1 and Hs3st3b1, reduces kidney and glomerular size and disrupts glomerular architecture.
Patel V, Ball J, Choi S, Lane E, Wang Z, Aure M
Matrix Biol. 2024; 133:134-149.
PMID: 38944161
PMC: 11402573.
DOI: 10.1016/j.matbio.2024.06.006.
Comparative study on muscle function in two different streptozotocin-induced diabetic models.
Aisyah R, Kamesawa M, Horii M, Watanabe D, Yoshida Y, Miyata K
Acta Diabetol. 2024; 61(11):1443-1453.
PMID: 38856757
PMC: 11531449.
DOI: 10.1007/s00592-024-02311-3.
Jiawei Shengjiangsan's Effect on Renal Injury in Diabetic Nephropathy Mice is Investigated via the PI3K/Akt/NF-κB Signaling Pathway.
Yang C, Huang F, Fang H, Zang Y
Diabetes Metab Syndr Obes. 2024; 17:1687-1698.
PMID: 38629025
PMC: 11020332.
DOI: 10.2147/DMSO.S456205.
Esm-1 mediates transcriptional polarization associated with diabetic kidney disease.
Gaudet A, Zheng X, Kambham N, Bhalla V
Am J Physiol Renal Physiol. 2024; 326(6):F1016-F1031.
PMID: 38601985
PMC: 11386982.
DOI: 10.1152/ajprenal.00419.2023.
Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
Taguchi S, Azushima K, Yamaji T, Suzuki T, Abe E, Tanaka S
Hypertens Res. 2023; 47(1):55-66.
PMID: 37957242
DOI: 10.1038/s41440-023-01496-4.
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease.
Mathew A, Kayampilly P, Byun J, Nair V, Afshinnia F, Chai B
Am J Physiol Renal Physiol. 2023; 326(1):F30-F38.
PMID: 37916286
PMC: 11194048.
DOI: 10.1152/ajprenal.00252.2022.
Super-Resolution Ultrasound Imaging of Renal Vascular Alterations in Zucker Diabetic Fatty Rats during the Development of Diabetic Kidney Disease.
Sogaard S, Bech Andersen S, Taghavi I, Schou M, Christoffersen C, Brings Jacobsen J
Diagnostics (Basel). 2023; 13(20).
PMID: 37892017
PMC: 10605617.
DOI: 10.3390/diagnostics13203197.
3D autofluorescence imaging of hydronephrosis and renal anatomical structure using cryo-micro-optical sectioning tomography.
Fan G, Jiang C, Huang Z, Tian M, Pan H, Cao Y
Theranostics. 2023; 13(14):4885-4904.
PMID: 37771780
PMC: 10526660.
DOI: 10.7150/thno.86695.
Galantamine improves glycemic control and diabetic nephropathy in Lepr mice.
Meng Q, Ma J, Suo L, Pruekprasert N, Chakrapani P, Cooney R
Sci Rep. 2023; 13(1):15544.
PMID: 37731032
PMC: 10511534.
DOI: 10.1038/s41598-023-42665-2.
Optimizing diabetic kidney disease animal models: Insights from a meta-analytic approach.
Li F, Ma Z, Cai Y, Zhou J, Liu R
Animal Model Exp Med. 2023; 6(5):433-451.
PMID: 37723622
PMC: 10614131.
DOI: 10.1002/ame2.12350.
Protective Factors and the Pathogenesis of Complications in Diabetes.
Yu M, Gordin D, Fu J, Park K, Li Q, King G
Endocr Rev. 2023; 45(2):227-252.
PMID: 37638875
PMC: 10911956.
DOI: 10.1210/endrev/bnad030.
Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.
Talukdar A, Basumatary M
Mol Biol Rep. 2023; 50(9):7759-7782.
PMID: 37458869
DOI: 10.1007/s11033-023-08621-z.
A flavonoid-rich fraction of attenuates hyperglycemia, insulin resistance, and oxidative stress in a type 2 diabetes rat model.
Alruhaimi R, Mostafa-Hedeab G, Abduh M, Bin-Ammar A, Hassanein E, Kamel E
Front Pharmacol. 2023; 14:1204641.
PMID: 37397470
PMC: 10311489.
DOI: 10.3389/fphar.2023.1204641.
Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR.
Wang Q, Qi H, Wu Y, Yu L, Bouchareb R, Li S
Nat Metab. 2023; 5(4):607-625.
PMID: 37024752
PMC: 10821741.
DOI: 10.1038/s42255-023-00776-0.
GSK3β Inhibition Reduced Vascular Calcification in Mice.
Bostrom K, Qiao X, Zhao Y, Wu X, Zhang L, Ma J
Int J Mol Sci. 2023; 24(6).
PMID: 36983045
PMC: 10054481.
DOI: 10.3390/ijms24065971.